Stata command for calculating adverse event and efficacy stopping boundaries for phase II single-arm trials

Bryan M. Fellman ()
Additional contact information
Bryan M. Fellman: MD Anderson Cancer Center

Stata Journal, 2014, vol. 14, issue 2, 407-417

Abstract: Many programs and functions in statistical packages focus on the final stage of clinical trials, that is, the data analysis. In this article, I aim to assist in the early stages of clinical trials, specifically, the design of phase II single-arm trials. I present the new command stopbound, which calculates stopping boundaries and operating characteristics based on monitoring an adverse event, efficacy, or an adverse event and efficacy. Copyright 2014 by StataCorp LP.

Keywords: stopbound; Bayesian clinical trial design; adverse event; efficacy rate; futility; simulation; operating characteristic (search for similar items in EconPapers)
Date: 2014
Note: to access software from within Stata, net describe http://www.stata-journal.com/software/sj14-2/st0344/
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.stata-journal.com/article.html?article=st0344 link to article purchase

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:tsj:stataj:v:14:y:2014:i:2:p:407-417

Ordering information: This journal article can be ordered from
http://www.stata-journal.com/subscription.html

Access Statistics for this article

Stata Journal is currently edited by Nicholas J. Cox and Stephen P. Jenkins

More articles in Stata Journal from StataCorp LLC
Bibliographic data for series maintained by Christopher F. Baum () and Lisa Gilmore ().